Table III.
Biological treatment in Felty’s syndrome based on avialable literature
| First author and year of publication | Biologic treatment | Treatment effectiveness |
|---|---|---|
| Ghavami et al. 2005 [7] | Etanercept | Partial |
| Kimura, Yoshida 2020 [8] | Abatacept | Successful |
| Li et al. 2020 [9] | Rituximab | Successful |
| Gupta et al. [10] | Adalimumab | Partial |
| Li et al. 2020 [11] | Tocilizumab | Successful |
| Tomi et al. 2012 [12] | Rituximab | Successful |
| Chandra et al. 2008 [13] | Rituximab | Successful |
| Wang 2018 [14] | Rituximab | Successful |
| Shipley et al. 2008 [15] | Rituximab | Successful |
| Lekharaju, Chattopadhyay 2008 [16] | Rituximab | Successful |
| Becker et al. 2014 [17] | Rituximab | Successful |
| Weinreb et al. 2006 [18] | Rituximab | Successful |
| Heylen et al. 2012 [19] | Rituximab | Successful |
| Pukšić et al. 2017 [20] | Rituximab | Successful |
| Sordet et al. 2005 [21] | Rituximab | Ineffective |
| Ayzenberg, Shenberge 2014 [22] | Rituximab | Successful |
| Salama et al. 2008 [23] | Rituximab | Successful |
| Sarp, Ataman 2014 [24] | Rituximab | Successful |